ARMK
Aramark
ARMK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over ARMK overall, supported by stronger fundamentals and stronger modeled upside.
ARMK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
ARMK's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
ARMK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $22.71 | -58% |
| Forward | 19x | $53.88 | — |
| Fair | 33x | $47.38 | -12% |
| Current | 38x | $53.88 | — |
| Expensive | 55x | $78.71 | +46% |
Historical ranges are pointers, not guarantees.
ARMK's PE is in its fair range at 38x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over ARMK in the historical PE scenario, which offers more potential upside but is not a forecast.
ARMK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARMK, with profitability holding steady.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over ARMK on the outlook, with more favorable profitability expectations.
ARMK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.82 | +97% |
| Q2 2026 | $1.43 | +5.9% |
| Q1 2026 | $1.34 | +3.1% |
| Q4 2025 | $1.19 | -6.3% |
| Q3 2025 | $1.22 | +23% |
| Q2 2025 | $1.35 | +2.3% |
| Q1 2025 | $1.30 | -46% |
| Q4 2024 | $1.27 | -47% |
| Q3 2024 | $0.99 | -61% |
ARMK has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
ARMK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.1B | +9.3% |
| Q1 2026 | $4.9B | +15% |
| Q4 2025 | $4.8B | +6.1% |
| Q3 2025 | $5B | +14% |
| Q2 2025 | $4.6B | +5.7% |
| Q1 2025 | $4.3B | +1.9% |
| Q4 2024 | $4.6B | +3.3% |
| Q3 2024 | $4.4B | -9.9% |
ARMK's revenue has grown year over year for seven quarters in a row: $5.1B last quarter, up 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | +0.3 points |
| Q1 2026 | 4.5% | +0.4 points |
| Q4 2025 | 4.5% | -0.3 points |
| Q3 2025 | 4.3% | -0.6 points |
| Q2 2025 | 4% | +0.3 points |
| Q1 2025 | 4.1% | +0.3 points |
| Q4 2024 | 4.8% | +1 points |
| Q3 2024 | 5% | -0.7 points |
ARMK's operating margin was 4.3% last quarter, about level with the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over ARMK on profitability, with a higher operating margin.
ARMK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.8M | +$39.5M |
| Q1 2026 | $299M | +113% |
| Q4 2025 | -$904.4M | -$197.3M |
| Q3 2025 | $1B | +17% |
| Q2 2025 | -$34.7M | -162% |
| Q1 2025 | $140.1M | +4.7% |
| Q4 2024 | -$707M | +$65.7M |
| Q3 2024 | $882.3M | -0.5% |
ARMK has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
ARMK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +2.1M shares |
| 1 year | +1.2% | +3.2M shares |
| 3 years | +2.2% | +5.8M shares |
| 5 years | +4.3% | +11.2M shares |
| Available history | +6.6% | +16.5M shares |
ARMK has 269M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $913,000 |
| Q1 2026 | $25.1M |
| Q4 2025 | $41.3M |
| Q3 2025 | $29.7M |
| Q2 2025 | $30.9M |
| Q3 2021 | — |
| Q2 2021 | — |
| Q3 2020 | — |
ARMK spent $97M buying back its own shares over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over ARMK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
ARMK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.2x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
| Q3 2024 | 4.0x | High |
ARMK's net debt is about 4.0 years of its operating earnings (EBITDA), down from 4.6 years a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over ARMK on leverage, with a lower net debt burden relative to earnings.
ARMK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.0 | Neutral |
| Stochastic | 23.6 | Neutral |
ARMK's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ARMK PE vs Industrials Sector
| Metric | ARMK | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 24x | 57% above |
| PE % | 55 | 58 | 3 pts below |
ARMK is trading at 38x earnings, a 57% premium to the Industrials sector's median of 24x.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over ARMK on valuation relative to its sector.
ARMK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.2 | 0.6% below |
| 20 week MA | $56.3 | 4.4% below |
| 50 week MA | $48.6 | 11% above |
| 100 week MA | $43.4 | 24% above |
| 200 week MA | $37.2 | 45% above |
ARMK has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
ARMK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.4 | $27.2 | -13% |
| 2021 | $27.2 | $26.0 | -4.2% |
| 2022 | $26.0 | $30.0 | +15% |
| 2023 | $30.0 | $28.1 | -6.2% |
| 2024 | $28.1 | $37.4 | +33% |
| 2025 | $37.4 | $37.4 | 0% |
| 2026 YTD | $37.4 | $53.9 | +44% |
ARMK has the edge over CAT on returns for 2026, with the stronger performance.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.